Mayne Pharma FY revenue A$383.7 million, down 6%
Mayne Pharma reported FY revenue of A$383.7 million, down 6%.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Mayne Pharma reported FY revenue of A$383.7 million, down 6%.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.